Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A: evidence of a long-lasting effect.
Kañovský
P
P
1st Department of Neurology, Masaryk University, St. Anne Hospital, Brno, Czech Republic.
Streitová
H
H
Bares
M
M
Hortová
H
H
D000328:Adult; D000368:Aged; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D008334:Mandible / Q000503:physiopathology*; D008406:Masseter Muscle / Q000503:physiopathology*; D008875:Middle Aged; D009055:Mouth / Q000503:physiopathology*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D013997:Time Factors; D014059:Tongue / Q000503:physiopathology*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A